VERTEX PHARMACEUTICALS INC / MA·4

Feb 12, 5:06 PM ET

Sachdev Amit 4

4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 12, 2026

Research Summary

AI-generated summary of this filing

Updated

Vertex (VRTX) EVP Sachdev Amit Sells 2,057 Shares for Taxes

What Happened
Sachdev Amit (EVP, Chief Patient & External Affairs Officer) disposed of 2,057 Vertex (VRTX) shares on Feb 10, 2026 to satisfy a tax or exercise-related liability. The shares were reported at $468.41 each, for a total value of approximately $963,519. The transaction is coded "F" on the Form 4, indicating withholding to cover tax or exercise costs rather than an open-market investment sale.

Key Details

  • Transaction date and price: Feb 10, 2026 — 2,057 shares at $468.41 each.
  • Total value: ~$963,519.
  • Transaction code: F (payment of exercise price or tax liability / shares withheld for taxes).
  • Shares owned after transaction: not specified in this filing.
  • Filing date: Feb 12, 2026 (reported within the usual two-business-day Form 4 window; not flagged as late).

Context
Tax-withholding dispositions are common when options vest or restricted shares settle; a portion of shares is retained or sold to meet tax obligations. This type of transaction is administrative (to cover taxes) and does not necessarily indicate the insider is taking a market view on the company.

Insider Transaction Report

Form 4
Period: 2026-02-10
Sachdev Amit
EVP Chief Patient & Ext Af Off
Transactions
  • Tax Payment

    Common Stock

    2026-02-10$468.41/sh2,057$963,51968,941 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    882
  • Common Stock

    (indirect: By Trust)
    9,301
Signature
/s/ Christiana Stevenson, Attorney-in-Fact|2026-02-12

Documents

1 file
  • 4
    wk-form4_1770933974.xmlPrimary

    FORM 4